Pharmaceutical dronedarone composition for parenteral administration

Details for Australian Patent Application No. 2002217229 (hide)

Owner Sanofi-Aventis

Inventors Bourriague-Seve, Frederique; Breul, Thierry

Agent Davies Collison Cave

Pub. Number AU-B-2002217229

PCT Pub. Number WO02/47660

Priority 00 16071 11.12.00 FR

Filing date 10 December 2001

Wipo publication date 24 June 2002

Acceptance publication date 18 May 2006

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

Event Publications

17 February 2005 Change of Name(s) of Applicant(s), Section 104

  Sanofi-Synthelabo The name of the applicant has been changed to Sanofi-Aventis

18 May 2006 Application Accepted

  Published as AU-B-2002217229

14 September 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002217230

2002217228